New Zealand markets open in 8 hours 30 minutes

Astellas Pharma Inc. (ALPMY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
9.48-0.20 (-2.07%)
At close: 03:59PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2025)Next year (2026)
No. of analysts0010
Avg. Estimate000.30
Low estimate000.30
High estimate000.30
Year ago EPSN/AN/A0.070.3
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2025)Next year (2026)
No. of analysts1010
Avg. Estimate10.82BN/A10.82BN/A
Low estimate10.82BN/A10.82BN/A
High estimate10.82BN/A10.82BN/A
Year ago sales11.09BN/A11.09B10.82B
Sales growth (year/est)-2.40%N/A-2.40%N/A
Earnings historyInvalid DateInvalid DateInvalid DateInvalid Date
Est. EPSN/AN/AN/AN/A
Actual EPSN/AN/AN/AN/A
DifferenceN/AN/AN/AN/A
Surprise %N/AN/AN/AN/A
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2025)Next year (2026)
Current estimate000.30
7 days ago000.30
30 days ago000.430
60 days ago000.430
90 days ago000.440
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2025)Next year (2026)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesALPMYIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year328.60%N/AN/AN/A
Next yearN/AN/AN/AN/A
Next 5 years (per annum)14.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A